🇺🇸 Immunosuppressants in United States

137 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 137

Most-reported reactions

1. Pyrexia — 22 reports (16.06%)
2. Pneumonia — 18 reports (13.14%)
3. Renal Failure — 16 reports (11.68%)
4. Drug Ineffective — 15 reports (10.95%)
5. Arthralgia — 12 reports (8.76%)
6. Pain — 12 reports (8.76%)
7. Death — 11 reports (8.03%)
8. Vomiting — 11 reports (8.03%)
9. Anaemia — 10 reports (7.3%)
10. Blood Creatinine Increased — 10 reports (7.3%)

Source database →

Frequently asked questions

Is Immunosuppressants approved in United States?

Immunosuppressants does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Immunosuppressants in United States?

Guang'anmen Hospital of China Academy of Chinese Medical Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.